NeoGenomics (MEX:NEO) Common Stock: MXN2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NEO NeoGenomics Inc MEX:NEO
73 GF Score
Price MXN176.40
GF Value MXN171.28
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Common Stock?

NeoGenomics MEX:NEO 73 Common Stock is MXN2 Mil as of Jun. 2026. GuruFocus rates MEX:NEO with a GF Score™ of 73/100 and a GF Value™ of MXN171.28. The stock has 6 warning signs investors should review.

NeoGenomics's quarterly common stock increased from Dec. 2025 (MXN2 Mil) to Mar. 2026 (MXN2 Mil) but then declined from Mar. 2026 (MXN2 Mil) to Jun. 2026 (MXN2 Mil).

NeoGenomics's annual common stock increased from Dec. 2023 (MXN2 Mil) to Dec. 2024 (MXN3 Mil) but then declined from Dec. 2024 (MXN3 Mil) to Dec. 2025 (MXN2 Mil).

NeoGenomics Common Stock Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Common Stock Chart

NeoGenomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 2.48 2.16 2.67 2.32

NeoGenomics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 2.35 2.32 2.33 2.27
MEX:NEO
73GF Score
NeoGenomics Inc MEX:NEO
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN2 Mil mean?
NeoGenomics (MEX:NEO) has a Common Stock of MXN2 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' Common Stock too high?
NeoGenomics' current Common Stock is MXN2 Mil. Overall, NeoGenomics has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' Common Stock compare to WGS and CDNA?
NeoGenomics' Common Stock of MXN2 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on NeoGenomics and its competitors. NeoGenomics's current Common Stock is MXN2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
NeoGenomics (MEX:NEO) has a current Common Stock of MXN2 Mil. The stock's GF Value™ is MXN171.28, compared to a current price of MXN176.40 — trading 3% above its estimated fair value. The current Common Stock is MXN2 Mil. NeoGenomics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For NeoGenomics (MEX:NEO), the current Common Stock is MXN2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (MEX:NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be overvalued. The current stock price of MXN176.40 is trading 3% above its estimated GF Value™ of MXN171.28.

Key valuation signals for MEX:NEO:

  • Common Stock: MXN2 Mil
  • GF Value™: MXN171.28 vs. price of MXN176.40 (3% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the MEX:NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeoGenomics Business Description

Other Exchanges NEO:USANG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
73GF Score

Get the complete analysis for MEX:NEO

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN176.40
Price
MXN171.28
GF Value